Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients

• OZEKI Itaru

  Department of Gastroenterology, Sapporo Kosei General Hospital

• AKAIKE Jun

  Department of Gastroenterology, Sapporo Kosei General Hospital

• KARINO Yoshiyasu

  Department of Gastroenterology, Sapporo Kosei General Hospital

• ARAKAWA Tomohiro

  Department of Gastroenterology, Sapporo Kosei General Hospital

• KUWATA Yasuaki

  Department of Gastroenterology, Sapporo Kosei General Hospital

• OHMURA Takumi

  Department of Gastroenterology, Sapporo Kosei General Hospital

• SATO Takahiro

  Department of Gastroenterology, Sapporo Kosei General Hospital

• KAMIYA Naohiro

  Research and Development Division, Mitsubishi Tanabe Pharma Corporation

• YAMADA Ichimaro

  Research and Development Division, Mitsubishi Tanabe Pharma Corporation

• CHAYAMA Kazuaki

  Programs for Biomedical Research, Division of Frontier Medical Science, Department of Medical and Molecular Science, Graduate School of Biomedical Science, Hiroshima University

• KUMADA Hiromitsu

  Department of Hepatology, Toranomon Hospital

• TOYOTA Joji

  Department of Gastroenterology, Sapporo Kosei General Hospital

Journal

• J Gastroenterol

  J Gastroenterol 46 (7), 929-937, 2011-07-01

Keywords

• Hepatitis C therapy
• Telaprevir
• Ribavirin
• Anemia

Details

• CRID: 1573105974851299712
• NII Article ID: 10029313367
• NII Book ID: AA10988015
• ISSN: 09441174
• Web Site: https://search.jamas.or.jp/link/ui/2012151847
• Text Lang: en
• Data Source:
  • CiNii Articles